42 research outputs found

    Yoga for Anxiety Management in the Workplace

    Get PDF
    Anxiety is a potential cause of serious influence in a person\u27s daily life. This chapter is focused specifically on the effects of the work environment factors in disease development and progression. Working environments are places of significant sources of stress: they put us in connection with our duties and expectations (often not coincide with reality) and with a "forced socialization." Especially forced socialization is to be considered a main source of stress in work places, inducing negative outcomes in work and social relationships. The psychosocial risks of work places can so be defined according to design, organization and management of work as well as to social and environmental contexts that may lead to damage of physical, social and psychological domains. Stress can then be defined as a pattern of emotional, cognitive, behavioral, and physiological reactions to adverse and noxious aspects perceived as the contents of the working environment. Thanks to the beginning of psychosocial research on the working environment, the impact of some aspects of the work environment on health has become an object of study, as the interventions to mitigate it. Yoga, meditation, and mantra techniques, as described in this work (presenting others’ experiences and two of own current projects, used in a hospital workplace to control the condition of occupational stress but also in a clinical sample), showed the potential in considerably reducing anxiety and mood symptoms

    Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium

    Get PDF
    ABSTRACT Background Advanced-stage mycosis fungoides (MF)/Sezary syndrome (SS) patients are weighted by an unfavorable prognosis and share an unmet clinical need of effective treatments. International guidelines are available detailing treatment options for the different stages but without recommending treatments in any particular order due to lack of comparative trials. The aims of this second CLIC study were to retrospectively analyze the pattern of care worldwide for advanced-stage MF/SS patients, the distribution of treatments according to geographical areas (USA versus non-USA), and whether the heterogeneity of approaches has potential impact on survival. Patients and methods This study included 853 patients from 21 specialist centers (14 European, 4 USA, 1 each Australian, Brazilian, and Japanese). Results Heterogeneity of treatment approaches was found, with up to 24 different modalities or combinations used as first-line and 36% of patients receiving four or more treatments. Stage IIB disease was most frequently treated by total-skin-electron-beam radiotherapy, bexarotene and gemcitabine; erythrodermic and SS patients by extracorporeal photochemotherapy, and stage IVA2 by polychemotherapy. Significant differences were found between USA and non-USA centers, with bexarotene, photopheresis and histone deacetylase inhibitors most frequently prescribed for first-line treatment in USA while phototherapy, interferon, chlorambucil and gemcitabine in non-USA centers. These differences did not significantly impact on survival. However, when considering death and therapy change as competing risk events and the impact of first treatment line on both events, both monochemotherapy (SHR = 2.07) and polychemotherapy (SHR = 1.69) showed elevated relative risks. Conclusion This large multicenter retrospective study shows that there exist a large treatment heterogeneity in advanced MF/SS and differences between USA and non-USA centers but these were not related to survival, while our data reveal that chemotherapy as first treatment is associated with a higher risk of death and/or change of therapy and thus other therapeutic options should be preferable as first treatment approach

    Modello commerciale Piemonte

    Get PDF
    Working Paper; n. 1

    Parto e disfunzioni perineali:l'importanza di una diagnosi precoce

    No full text
    Gravidanza e parto per via vaginale rappresentano i principali fattori di rischio per l'incontinenza urinaria da sforzo(IUS). Durante la gravidanza si ha una fisiologica riduzione della forza dei muscoli del pavimento pelvico a partire dalla 20^ settimana fino alla 6^ settimana di puerperio e questo compromette la naturale funzionalit\ue0 del pavimento pelvico. Un training muscolare eseguito durante la gravidanza e nel primo puerperio consente di contrastare gli effetti negativi che gravidanza e parto possono svolgere sul pavimento pelvico: aumento della pressione addominale, aumento di lassit\ue0 del sistema di sospensione, modificazioni della statica pelvica, traumi diretti da parto, con una riduzione dell'incidenza di IU

    Prevenzione delle infezioni ricorrenti delle vie urinarie in donne in et\ue0 fertile.

    No full text
    Le infezioni delle vie urinarie(IVU) sono una delle forme infettive batteriche pi\uf9 frequenti nella specie umana, soprattutto nel sesso femminile. Dai 20 ai 40 anni il 40% delle donne riferisce di aver avuto almeno una IVU e il rischio di cistite ricorrente \ue8 pari al 20%. Le linee guida pevedono una prolungata profilassi antibiotica per prevenire il rischio di IVU, tuttavia le donne non eseguono volentieri questa terapia. Gli Autori hanno valutato se la somministrazione di un prodotto contenente cranberry e L-metionina possa essere utile nella prevenzione delle cistiti ricorrenti.60 pazienti con anamnesi positiva per cistiti ricorrenti sono state suddivise random in due gruppi, di cui il primo \ue8 stato supplementato con cramberry e metionina, il secondo usato come controllo. al momento del reclutamento le donne erano libere da infezione, controlli sono stati eseguiti a 3 6 12 mesi. Il gruppo supplementato ha evidenziato un maggior numero di infezioni nei primi 3 mesi, poi ha fatto registrare una progressiva riduzione delle infezioni rispetto al controllo che ha concluso il follow-up con un 5% di IVU in pi\uf9.Buona la compliance delle pazienti per il prodotto

    Valutazione delle quote di mercato e dei livelli di modernizzazione del sistema distributivo alimentare per aree subregionali

    Get PDF
    Working Paper; n. 7
    corecore